Hans Petter Eikesdal

Author

Also Known As

Eikesdal, Hans P., Eikesdal, Hans Petter, H. P. Eikesdal, H.P. Eikesdal, Hans P Eikesdal, Hans P. Eikesdal, Hans Petter Eikesdal, Hans Petter Petter Eikesdal

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Bergen Haukeland University Hospital Akershus University Hospital University of Oslo St Olav's University Hospital

About

Hans Petter Eikesdal is an author at University of Bergen specializing in medicine, tumor microenvironment, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	397
2	Cell Biology	4	4	111
3	Pathology	4	4	263
4	Immunology	3	3	258
5	Neurology	1	1	18

Hans Petter Eikesdal

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Olaparib monotherapy as primary treatment in unselected triple negative breast cancer Hans Petter Eikesdal, Synnøve Yndestad, Ahmed El‐Zawahry, Annals of Oncology	2020	210
Lymphatic vessels regulate immune microenvironments in human and murine melanoma Amanda W. Lund, Marek Wagner, Manuel Fankhauser, Journal of Clinical Investigation ImmunologyPathologyImmunologic MechanismDermatologyImmunotherapy	2016	187
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study Hildegunn Høberg‐Vetti, Cathrine Bjorvatn, Bent Fiane, European Journal of Human Genetics	2015	73
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity Hans Petter Eikesdal, Hikaru Sugimoto, Gabriel Birrane, Proceedings of the National Academy of Sciences	2008	63
A novel eGFP‐expressing immunodeficient mouse model to study tumor‐host interactions Simone P. Niclou, Claude Danzeisen, Hans Petter Eikesdal, The FASEB Journal	2008	62
Constitutional <i>BRCA1</i> Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer Per Eystein Lønning, Oleksii Nikolaienko, Kathy Pan, JAMA Oncology	2022	54
Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension Cornelia Schuster, Hans Petter Eikesdal, Hanne Puntervoll, PLoS ONE	2012	52
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype Lin Wang, Dan Wang, Olmo Sonzogni, Cell Reports Breast OncologyParp-inhibition ReprogramsMedicineImmunologyCancer Growth	2022	52
Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors Hans Petter Eikesdal, Rolf Bjerkvig, Olav Mella, Radiotherapy and Oncology HyperthermiaSolid TumorsMedicinePathologyThermal Therapy	2001	39
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers Felipe Batalini, D. Gulhan, Victor Y. Mao, Clinical Cancer Research	2022	39

Page 1